Insulin-like growth factor receptor (IGF-1R) in breast cancer subtypes. (Q38410339)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21574055%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

title

Insulin-like growth factor receptor (IGF-1R) in breast cancer subtypes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21574055%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21574055%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

7

Gulisa Turashvili

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21574055%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

author name string

Rinat Yerushalmi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21574055%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Karen A Gelmon

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21574055%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Samuel Leung

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21574055%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Dongxia Gao

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21574055%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Michael Pollak

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21574055%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Blakes C Gilks

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21574055%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Hagen Kennecke

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21574055%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

language of work or name

English

0 references

publication date

15 May 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21574055%20AND%20SRC:MED&resulttype=core&format=json

Breast Cancer Research and Treatment

1 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21574055%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

volume

132

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21574055%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21574055%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

page(s)

131-142

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21574055%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10549-011-1529-8

1 February 2020

exact match

0 references

cites work

Characterization of human placental insulin-like growth factor-I/insulin hybrid receptors by protein microsequencing and purification

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1529-8

Structure and function of the type 1 insulin-like growth factor receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1529-8

Antixenograft tumor activity of a humanized anti-insulin-like growth factor-I receptor monoclonal antibody is associated with decreased AKT activation and glucose uptake.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1529-8

Crosstalk between IGF1R and estrogen receptor signaling in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1529-8

The insulin-like growth factor-I receptor gene: a downstream target for oncogene and tumor suppressor action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1529-8

Phosphorylated insulin-like growth factor-i/insulin receptor is present in all breast cancer subtypes and is related to poor survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1529-8

Expression of insulin-like growth factor 1 receptor in primary breast cancer: immunohistochemical analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1529-8

Emerging role of insulin-like growth factor receptor inhibitors in oncology: early clinical trial results and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1529-8

Substrate competitive inhibitors of IGF-1 receptor kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1529-8

In vivo antitumor activity of NVP-AEW541-A novel, potent, and selective inhibitor of the IGF-IR kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1529-8

Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1529-8

Insulin-like growth factor receptor levels are regulated by cell density and by long term estrogen deprivation in MCF7 human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1529-8

Down-regulation of insulin receptor by antibodies against the type I insulin-like growth factor receptor: implications for anti-insulin-like growth factor therapy in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1529-8

Cross-talk between the ErbB/HER family and the type I insulin-like growth factor receptor signaling pathway in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1529-8

Dysregulated PI3K/Akt/PTEN pathway is a marker of a short disease-free survival in node-negative breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1529-8

Quantitative immunocytochemical profile to predict early outcome of disease in triple-negative breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1529-8

A candidate molecular signature associated with tamoxifen failure in primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1529-8

Prognostic marker profile to assess risk in stage I-III hormone receptor-positive breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1529-8

GATA-3 expression in breast cancer has a strong association with estrogen receptor but lacks independent prognostic value

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1529-8

Insulin receptor is an independent predictor of a favorable outcome in early stage breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1529-8

Coexpression of IGF-1R and c-Src proteins in human pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1529-8

Changes in biomarkers of estrogen receptor and growth factor signaling pathways in MCF-7 tumors after short- and long-term treatment with soy and flaxseed.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1529-8

Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1529-8

Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1529-8

Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1529-8

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1529-8

Stromal mast cells in invasive breast cancer are a marker of favourable prognosis: a study of 4,444 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1529-8

Impact of inbreeding on fertility in a pre-industrial population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1529-8

Proteomic and transcriptomic profiling reveals a link between the PI3K pathway and lower estrogen-receptor (ER) levels and activity in ER+ breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1529-8

Insulin-like growth factor-I activates gene transcription programs strongly associated with poor breast cancer prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1529-8

The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1529-8

Synergic antitumoral effect of an IGF-IR inhibitor and trastuzumab on HER2-overexpressing breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1529-8

Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1529-8

HER receptor signaling confers resistance to the insulin-like growth factor-I receptor inhibitor, BMS-536924.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1529-8

Co-targeting the insulin-like growth factor I receptor enhances growth-inhibitory and pro-apoptotic effects of anti-estrogens in human breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1529-8

IGF-1 receptor inhibitors in clinical trials--early lessons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1529-8

Insulin-like growth factor-I receptor signalling and acquired resistance to gefitinib (ZD1839; Iressa) in human breast and prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1529-8

Insulin-like growth factor-I receptor/human epidermal growth factor receptor 2 heterodimerization contributes to trastuzumab resistance of breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1529-8

Insulin-like growth factor-I receptor signaling and resistance to trastuzumab (Herceptin).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1529-8

Development of an integrated genomic classifier for a novel agent in colorectal cancer: approach to individualized therapy in early development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1529-8

How to train your biomarker.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1529-8

10.1007/S10549-011-1529-8

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21574055%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

1 February 2020

1026401084

0 references

1 reference